Cargando…
From molecular signatures to predictive biomarkers: modeling disease pathophysiology and drug mechanism of action
Omics profiling significantly expanded the molecular landscape describing clinical phenotypes. Association analysis resulted in first diagnostic and prognostic biomarker signatures entering clinical utility. However, utilizing Omics for deepening our understanding of disease pathophysiology, and fur...
Autores principales: | Heinzel, Andreas, Perco, Paul, Mayer, Gert, Oberbauer, Rainer, Lukas, Arno, Mayer, Bernd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207010/ https://www.ncbi.nlm.nih.gov/pubmed/25364744 http://dx.doi.org/10.3389/fcell.2014.00037 |
Ejemplares similares
-
Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease
por: Heerspink, Hiddo J. L., et al.
Publicado: (2019) -
Vascular endothelial growth factor A as predictive marker for mTOR inhibition in relapsing high-grade serous ovarian cancer
por: Andorfer, Peter, et al.
Publicado: (2016) -
Integrative Bioinformatics Analysis of Proteins Associated with the Cardiorenal Syndrome
por: Mühlberger, Irmgard, et al.
Publicado: (2010) -
Molecular Pathogenesis of Post-Transplant Acute Kidney Injury: Assessment of Whole-Genome mRNA and MiRNA Profiles
por: Wilflingseder, Julia, et al.
Publicado: (2014) -
Biomarker candidates for cardiovascular disease and bone metabolism disorders in chronic kidney disease: a systems biology perspective
por: Perco, Paul, et al.
Publicado: (2008)